Exicure (XCUR) Cash from Investing Activities Growth (1y) (2017 - 2023)
Exicure (XCUR) Cash from Investing Activities Growth (1y) (2017 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Exicure |
17.53 Mn |
14.92 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2023 |
243.48% |
| Jun 30, 2023 |
-226.67% |
| Mar 31, 2023 |
-94.69% |
| Dec 31, 2022 |
-94.96% |
| Sep 30, 2022 |
-77.54% |
| Jun 30, 2022 |
-92.22% |
| Mar 31, 2022 |
-86.96% |
| Dec 31, 2021 |
-69.51% |
| Sep 30, 2021 |
-21.14% |
| Jun 30, 2021 |
443.70% |
| Mar 31, 2021 |
222.35% |
| Dec 31, 2020 |
121.39% |
| Sep 30, 2020 |
1,508.75% |
| Jun 30, 2020 |
6,651.85% |
| Mar 31, 2020 |
-156,187.50% |
| Dec 31, 2019 |
-217,037.93% |
| Sep 30, 2019 |
-7,900.00% |
| Jun 30, 2019 |
10.00% |
| Dec 31, 2018 |
85.50% |
| Jun 30, 2018 |
59.73% |
